EXAI Stock
4.84
{{ price }}
0.000000%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NasdaqGS
Market Cap
0
LOW - HIGH [24H]
0.0000
-
0.0000
VOLUME [24H]
0
{{ volume }}
P/E Ratio
0
Earnings per share
0
Price Chart
EXAI Financial and Trading Overview
| stock price | 4.84 |
| Previous Close | 6.94 |
| Open | 6.86 |
| Bid | 0 x 1400 |
| Ask | 0 x 800 |
| Day's Range | 6.76 - 7.26 |
| 52 Week Range | 4.09 - 14.27 |
| Volume | 302.68K |
| Avg. Volume | 373.54K |
| Market Cap | 884.52M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 14.75 |
EXAI Valuation Measures
| Enterprise Value | 456.68M |
| Trailing P/E | N/A |
| Forward P/E | -4.022472 |
| PEG Ratio (5 yr expected) | 0.07 |
| Price/Sales (ttm) | 34.00814 |
| Price/Book (mrq) | 1.9757173 |
| Enterprise Value/Revenue | 17.558 |
| Enterprise Value/EBITDA | -2.604 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -44.83% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 14.27 |
| 52 Week Low | 4.09 |
| 50-Day Moving Average | 6.14 |
| 200-Day Moving Average | 6.68 |
EXAI Share Statistics
| Avg. Volume (3 month) | 373.54K |
| Avg. Daily Volume (10-Days) | 336.04K |
| Shares Outstanding | 123.54M |
| Float | 104.42M |
| Short Ratio | 3.51 |
| % Held by Insiders | 27.87% |
| % Held by Institutions | 28.28% |
| Shares Short | 1.4M |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 1.14% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -705.92% |
| Gross Margin | -38.90% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -17.36% |
| Return on Equity (ttm) | -28.15% |
Income Statement
| Revenue (ttm) | 26.01M |
| Revenue Per Share (ttm) | 0.21 |
| Quarterly Revenue Growth (yoy) | -17.39% |
| Gross Profit (ttm) | N/A |
| EBITDA | -175368000 |
| Net Income Avi to Common (ttm) | -140879008 |
| Diluted EPS (ttm) | -1.36 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 447.36M |
| Total Cash Per Share (mrq) | 3.62 |
| Total Debt (mrq) | 19.52M |
| Total Debt/Equity (mrq) | 4.36 |
| Current Ratio (mrq) | 7.031 |
| Book Value Per Share (mrq) | 3.624 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -88258000 |
| Levered Free Cash Flow (ttm) | -45293248 |
Profile of
| Country | United States |
| State | N/A |
| City | Oxford |
| Address | The SchrOedinger Building |
| ZIP | OX4 4GE |
| Phone | 44 18 6581 8941 |
| Website | https://www.exscientia.ai |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 481 |
Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. It also focuses on discovery and development of small molecule drug candidates. The company's platform enables to design candidate drug molecules, as well as to provide patients with drug therapies through AI guided assessment. Exscientia plc was founded in 2012 and is headquartered in Oxford, the United Kingdom.
Q&A For Stock
What is a current EXAI stock price?
EXAI stock price today per share is 4.84 .
How to purchase stock?
You can buy EXAI shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ?
The stock symbol or ticker of is EXAI.
Which industry does the company belong to?
The industry is Biotechnology.
How many shares does have in circulation?
The max supply of shares is 0.
What is Price to Earnings Ratio (PE Ratio)?
PE Ratio is 0.00000000 now.
What was earnings per share over the trailing 12 months (TTM)?
EPS is 0 over the trailing 12 months.
Which sector does the company belong to?
The sector is Healthcare.
EXAI included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17601.05 USD — |
+0.87
|
8.38B USD — | 17181.27 USD — | 17716.52 USD — | — - | 8.38B USD — |
| NASDAQ Global Select Market Com NQGS | 8613.57 USD — |
+0.85
|
— — | 8409.7 USD — | 8670.37 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4209.36 USD — |
+1.85
|
— — | 4100.47 USD — | 4211.44 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 942.47 USD — |
+1.43
|
— — | 920.56 USD — | 943.62 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4486.38 USD — |
-0.37
|
— — | 4281.91 USD — | 4648.11 USD — | — - | — — |
- {{ link.label }} {{link}}